GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Gayatri Rubbers and Chemicals Ltd (NSE:GRCL) » Definitions » Net Change in Cash

Gayatri Rubbers and Chemicals (NSE:GRCL) Net Change in Cash : ₹-15.8 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Gayatri Rubbers and Chemicals Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Gayatri Rubbers and Chemicals's Net Change in Cash for the six months ended in Mar. 2024 was ₹-15.8 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was ₹-15.8 Mil.

Gayatri Rubbers and Chemicals Net Change in Cash Historical Data

The historical data trend for Gayatri Rubbers and Chemicals's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gayatri Rubbers and Chemicals Net Change in Cash Chart

Gayatri Rubbers and Chemicals Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Net Change in Cash
-0.16 -1.72 0.36 19.91 -15.78

Gayatri Rubbers and Chemicals Semi-Annual Data
Mar20 Mar21 Mar22 Mar23 Mar24
Net Change in Cash -0.16 -1.72 0.36 19.91 -15.78

Gayatri Rubbers and Chemicals Net Change in Cash Calculation

Gayatri Rubbers and Chemicals's Net Change in Cash for the fiscal year that ended in Mar. 2024 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-3.05+-14.733+2.005+0
=-15.8

Gayatri Rubbers and Chemicals's Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-3.05+-14.733+2.005+0
=-15.8

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was ₹-15.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gayatri Rubbers and Chemicals Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Gayatri Rubbers and Chemicals's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Gayatri Rubbers and Chemicals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Gayatri Rubbers and Chemicals Ltd (NSE:GRCL) » Definitions » Net Change in Cash
Comparable Companies
NSE:MAHICKRA BOM:524324 BOM:506910 BOM:543497 BOM:539939 BOM:534598 BOM:540204 BOM:540550 NSE:REXPIPES NSE:AMBANIORG LIN XPAR:AI APD SHW ECL XSWX:SIKA SHSE:600309 BOM:500820 DD XSWX:GIVN
Traded in Other Exchanges
N/A
Address
Malerna Road, Plot No. 11, Gali No. 3, Opposite Beri ka Bagh, Ballabgarh, Faridabad, HR, IND, 121004
Website
https://www.gayatrirubberchemicals.com
Gayatri Rubbers and Chemicals Ltd is engaged in manufacturing and trading rubber products. The company's product portfolio includes Aluminium rubber profiles, Automobile rubber profiles, Sponge rubber components, Clear PVC profiles, Industrial rubber, and Railway sector rubber. Geographically, the company operates within India.

Gayatri Rubbers and Chemicals Headlines

From GuruFocus

Gracell Biotechnologies to Present Updated Clinical Data on BCMA/CD19 Dual-Targeting FasTCAR-T GC012F in Newly Diagnosed Multiple Myeloma at the 2023 International Myeloma Society Annual Meeting

By PRNewswire • 09-06-2023

Gracell Biotechnologies to Participate in BTIG Virtual Biotechnology Conference

By Marketwired • 07-31-2023

Gracell Biotechnologies to Report Second Quarter 2023 Financials on Monday, August 14, 2023

By Marketwired • 07-31-2023

Gracell Biotechnologies to Report Third Quarter 2023 Financials on Monday, November 13, 2023

By Marketwired • 10-30-2023

Gracell Biotechnologies to Participate in Two Upcoming Investor Conferences

By sperokesalga sperokesalga • 03-22-2023

Gracell Biotechnologies Doses First Patient in Phase 1b/2 Clinical Trial in U.S. Evaluating GC012F for Treatment of Relapsed/Refractory Multiple Myeloma

By Marketwired • 09-26-2023

Gracell Biotechnologies Announces Filing of Its Annual Report on Form 20-F for Fiscal Year 2022

By sperokesalga sperokesalga • 04-25-2023

Gracell Biotechnologies to Participate in Oppenheimer 33rd Annual Healthcare Conference

By PRNewswire PRNewswire • 02-28-2023

Gracell Biotechnologies Announces Up to $150 Million Private Placement Financing Joined by a Syndicate of Premier Healthcare Investors

By PRNewswire • 08-07-2023

Gracell Biotechnologies' CEO Dr. William Cao Named to Prestigious PharmaVoice 100, Honoring Most Inspiring Life Science Leaders

By Marketwired • 09-19-2023